ARTICLE · 31 DECEMBER 2025

E.O. Directs AG To Complete Marijuana Schedule III Rescheduling

Hyman, Phelps, & McNamara

Explore more from Hyman, Phelps, & McNamara

President Donald Trump signed an Executive Order on Thursday last week directing the Attorney General to expedite completion of marijuana rescheduling begun...

United StatesCannabis & Hemp

President Donald Trump signed an Executive Order on Thursday last week directing the Attorney General to expedite completion of marijuana rescheduling begun in October 2022 to facilitate medical research. There was uncertainty whether President Trump, now in the White House, would support rescheduling. Candidate Trump posted in September 2024, "As President, we will continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws, including safe banking for state authorized companies, and supporting states' rights to pass marijuana laws, like in Florida." Donald Trump (@realDonaldTrump), Truth Social (Sept. 8, 2024 at 23:18 ET).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

Related Articles

"Marijuana" Rescheduling Delayed, Again. What It Could Mean, And What Comes Next

United StatesCannabis & Hemp

Harris Sliwoski

The Week In Weed: October 2, 2026

United StatesCannabis & Hemp

Seyfarth Shaw LLP

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

United StatesCannabis & Hemp

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

United StatesCannabis & Hemp

Harris Sliwoski

Cannabis Meets Chapter 15: How The Cannabist Company Achieved Unprecedented US Bankruptcy Protection — And What It Means For Creditors

United StatesCannabis & Hemp

Herbert Smith Freehills Kramer LLP

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Cannabis & Hemp

Is Marijuana Rescheduling Finally Happening? What To Know, Now.

Yesterday afternoon, the Washington Post and other sources reported that President Trump is expected to issue an executive order directing federal agencies to reclassify marijuana...

United StatesCannabis & Hemp

Harris Sliwoski

Cannabis Rescheduling Arrives, With Limits: What The DOJ's Final Order Does And Doesn't Do

Alexander G. Malyshev and Sarah H. Ganley examine the final order rescheduling cannabis from Schedule I to Schedule III of the Controlled Substances Act. The analysis clarifies that this rescheduling applies specifically to medical cannabis and does not constitute federal legalization of cannabis.

United StatesCannabis & Hemp

Carter Ledyard & Milburn LLP

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests from cannabis sellers, alcohol producers, and state regulators creating policy gridlock, the future of intoxicating hemp products remains uncertain as midterm elections approach.

United StatesCannabis & Hemp

Harris Sliwoski

The Week In Weed: October 2, 2026

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, the DEA decided to pause its consideration of adult-use marijuana rescheduling.

United StatesCannabis & Hemp

Seyfarth Shaw LLP

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

The landscape surrounding Section 280E of the Internal Revenue Code continues to evolve with President Trump's Executive Order on medical marijuana rescheduling, advancing litigation in New Mexico Top Organics v. Commissioner, and shifting regulatory signals. Cannabis taxpayers face critical decisions about taking "non-280E" positions on their tax returns while the IRS maintains its enforcement stance and the U.S. Tax Court case addressing common arguments remains pending.

United StatesCannabis & Hemp

Federal Hemp Ban Signed Into Law: Enforcement Timeline, Impacts, And Strategies

On November 12, 2025 the President signed the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (H.R. 5371) into law.

United StatesCannabis & Hemp

Scarinci Hollenbeck LLC

DEA Recommendation To Reschedule Cannabis Is Imminent

Multiple news sources reported today that the DEA will be recommending rescheduling cannabis to a Schedule III drug.

United StatesCannabis & Hemp

Duane Morris LLP

Federal Cannabis Rescheduling: What Oklahoma OMMA Businesses Need To Know

On April 23, 2026, U.S. Attorney General Todd Blanche signed a final order moving FDA-approved marijuana drug products and state-licensed medical cannabis from Schedule I to Schedule III of the Controlled Substances Act.

United StatesCannabis & Hemp

Cantrell Law Firm

What Reclassification Of Marijuana Could Mean For Security Clearance Holders

If you are a security clearance holder, or looking to obtain one in the near future, you may be aware that reclassification of marijuana (cannabis, weed, pot) from a Schedule I drug to a Schedule III...

United StatesCannabis & Hemp

A Long Time Coming: Michigan Regulator Finally Issues Guidance On Penalties

Today, the Michigan Cannabis Regulatory Agency (the "CRA") published a much-anticipated schedule of disciplinary guidelines after months of requests from stakeholders throughout the industry...

United StatesCannabis & Hemp